1276. Deputy Barry Ward asked the Minister for Health the actions she will take to support women seeking alternative menopause treatments due to them being unable to take HRT for medical reasons, specifically in relation to the significant financial burden the cost of these treatments place on them. [64941/26]
Parliamentary questions
Questions
TDs ask ministers questions to get answers on the record, most of them in writing. Here is every one asked in the 34th Dáil, by the department it went to and the subject heading it was filed under. How questions work
Browse the questions
Showing questions asked by Barry Ward under the heading Medicinal Products.
39 questions match, newest first.
1277. Deputy Barry Ward asked the Minister for Health if her attention has been drawn to the concerns of women seeking alternative menopause treatments due to them being unable to take HRT for medical reasons, specifically in relation to the significant financial burden the cost of these treatments place on them. [64940/26]
1281. Deputy Barry Ward asked the Minister for Health her views on the merits of financially supporting alternative menopause treatments for women who cannot take HRT for medical reasons. [64939/26]
1282. Deputy Barry Ward asked the Minister for Health the position regarding any research ongoing in her Department into the merits of financially supporting alternative menopause treatments for women who cannot take HRT for medical reasons. [64938/26]
3305. Deputy Barry Ward asked the Minister for Health the position regarding negotiations ongoing in relation to the approval for reimbursement status of a drug (details supplied), which is used as part of the wider treatment of some cancers; and if she will make a statement on the matter. [55769/26]
3306. Deputy Barry Ward asked the Minister for Health the action she will take to engage with the HSE to expedite delays in relation to the approval for reimbursement status of a drug (details supplied) which is used as part of the wider treatment of some cancers; and if she will make a statement on the matter. [55770/26]
3307. Deputy Barry Ward asked the Minister for Health if she will consider facilitating a meeting with a person diagnosed with cancer and their supporters in relation to adding a cancer treatment to the list of approved drugs for reimbursement (details supplied); and if she will make a statement on the matter. [55771/26]
3308. Deputy Barry Ward asked the Minister for Health the reason that a drug used in the treatment of cancer (details supplied) is not available for reimbursement status for patients in Ireland in spite of its widespread use in the EU and approval for use by the European Medicines Agency; and if she will make a statement on the matter. [55772/26]
3309. Deputy Barry Ward asked the Minister for Health if her attention has been drawn to a detailed submission in relation to adding a cancer treatment to the list of approved drugs for reimbursement (details supplied); and if she will make a statement on the matter. [55773/26]
3359. Deputy Barry Ward asked the Minister for Health if her attention has been drawn to the case of a person (details supplied); the steps she will take to ensure that they have access to the level of treatment required; and if she will make a statement on the matter. [56012/26]
1969. Deputy Barry Ward asked the Minister for Health her views on if delays in the approval of skyclarys as a treatment for friedrich's ataxia aligns with the "equitable access" as outlined in the National Rare Disease Strategy 2025-2030; and if she will make a statement on the matter. [41993/26]
1973. Deputy Barry Ward asked the Minister for Health her views on whether the treatment for friedrich's ataxia falls under an 'unmet need' as set out in the National Rare Diseases Strategy 2025-2030; and if she will make a statement on the matter. [41997/26]
2232. Deputy Barry Ward asked the Minister for Health the position regarding the decision process behind the review by the HSE Drugs Group regarding the reimbursement of risdiplam for adults living with spinal muscular atrophy (SMA); and if she will make a statement on the matter. [43302/26]
354. Deputy Barry Ward asked the Minister for Health if her attention has been drawn to a campaign related to access to continuous glucose monitoring (details supplied); the actions she will take to engage with this campaign; and if she will make a statement on the matter. [38555/26]
355. Deputy Barry Ward asked the Minister for Health the position regarding any review of access to HSE supports for continuous glucose monitoring that would include those originally diagnosed with not being insulin dependent, but this diagnosis subsequently changing (details supplied); and if she will make a statement on the matter. [38556/26]
356. Deputy Barry Ward asked the Minister for Health her views on the fairness of the discrepancy in access to HSE supports for continuous glucose monitoring (details supplied); and if she will make a statement on the matter. [38557/26]
1228. Deputy Barry Ward asked the Minister for Health the position regarding the approvement process for a drug (details supplied) for the treatment of bronchiectasis; and if she will make a statement on the matter. [37704/26]
1229. Deputy Barry Ward asked the Minister for Health the position regarding a timeline for the approval for a drug (details supplied) for the treatment of bronchiectasis; and if she will make a statement on the matter. [37705/26]
1230. Deputy Barry Ward asked the Minister for Health the position regarding any engagement she has had with the HPRA in relation to the approval for a drug (details supplied) for the treatment of bronchiectasis; and if she will make a statement on the matter. [37706/26]
1231. Deputy Barry Ward asked the Minister for Health if she will set out the mechanism and timeframe of reference for the HPRA to approve the use of a particular pharmaceutical; and if she will make a statement on the matter. [37707/26]
871. Deputy Barry Ward asked the Minister for Health if her attention has been drawn to delays in the sign off of fertility treatment by the Health Products Regulatory Authority (details supplied); the actions she will take to address this matter; and if she will make a statement on the matter. [32100/26]
872. Deputy Barry Ward asked the Minister for Health if her attention has been drawn to significant delays in the sign off of fertility treatment for a family (details supplied); the actions she will take to ensure they are supported; and if she will make a statement on the matter. [32101/26]
1134. Deputy Barry Ward asked the Minister for Health the position regarding any research being carried out into the viability of providing treatment for people suffering from Friedrichs ataxia in Ireland; and if she will make a statement on the matter. [32792/26]
1136. Deputy Barry Ward asked the Minister for Health the position regarding the approval process for skyclarys as a treatment for Friedrichs ataxia; and if she will make a statement on the matter. [32794/26]
1137. Deputy Barry Ward asked the Minister for Health her views on whether the delays in the approval of skyclarys as a treatment for Friedrichs ataxia aligns with the "equitable access" as outlined in the National Rare Disease Strategy 2025-2030; and if she will make a statement on the matter. [32795/26]